1.4 Pos/ Symp/s: most common treatment. Eff/ for 70%. Julien (2005) -
reduce pos/ symp/s + decrease av/r length time hospitalised.
Relatively norm/ life in community. "Long Stay" to "Short Stay" condition.
1.5 Wide Range Symp/s: eff/ for some not
others. Substantial proportion not helped.
1.6 When to Measure: episodic -
periods symp/ free.
1.7 Placebo Effects: Receiving attention,
therapist / benefitting specific
therapy. Overcome by using control
group (waiting list patients)
1.8 APPROPRIATENESS: Side Effects: serious -
20-25% disordered motor movements
(tremors, involuntary tics (Tardive Dyskenesia))
1.8.1 50% stop 1st year. Harm - ppl prefer not to take.
2 ATYPICAL ANTIPSYCHOTICS
2.1 Range of drugs as eff/ as conventional but avoid problems.
2.2 Clozapine - eff/ pos/
symp/s when indiv/s